| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |